June 8, 2018 – Sen. Claire McCaskill (D-Mo.), who announced a bill in March that would amend the tax code to “deny the deduction for advertising and promotional expenses for prescription drugs,” continues to look for ways to restrict prescription drug company activities, now introducing a bill that would significantly expand reporting under the Sunshine Act.

According to Policy & Medicine, the “Patient Advocacy Transparency Act of 2018” would “expand Open Payment reporting to include television programs, websites, payments to patient advocacy organizations, professional societies, clinical trial organizations, and continuing medical education providers.

“McCaskill, author of the anti-consumer advertising bill, is really piling on, attempting to expand the Sunshine act to patient organizations, doctor groups and other collaborators with industry,” said Coalition for Healthcare Communication Executive Director John Kamp.

Read the full Policy & Medicine article at: https://bit.ly/2JkCbT9